Abstract
AKT/protein kinase B (PKB) is a cardinal node in diverse signaling cascades important in both normal cellular physiology and various disease states. AKT signaling regulates cell proliferation and survival, cell growth (size), glucose metabolism, cell motility and angiogenesis. Aberrant regulation of these processes result in cellular perturbations considered hallmarks of cancer, and numerous studies testify to the frequent hyperactivation of AKT signaling in many human cancers. Various oncoproteins and tumor suppressors intersect the AKT signal transduction pathway and are activated or inactivated, respectively, in cancer. This issue of Oncogene Reviews includes a collection of perspectives on the normal cellular functions of various components of the AKT pathway, as well as biological consequences of alterations of these proteins as related to tumorigenesis. Two reviews focus on AKT regulation, one of which addresses various aspects of phosphoinositide metabolism, while the other emphasizes the role of AKT-interacting proteins in AKT activation. Several reviews highlight the role of major AKT substrates involved in cellular metabolism, transcription and translation; another focuses on the role of AKT signaling in epithelial–mesenchymal transition. Also included are articles on the involvement of AKT pathway deregulation in human cancer and certain hereditary cancer syndromes, as well as in murine models of cancer based on AKT pathway activation. Additional articles discuss current approaches to identify selective inhibitors of the AKT pathway.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahmed NN, Franke TF, Bellacosa A, Datta K, Gonzalez-Portal ME, Taguchi T, Testa JR and Tsichlis PN . (1993). Oncogene, 8, 1957–1963.
Bellacosa A, Kumar CC, Di Cristofano A and Testa JR . (2005). Adv. Cancer Res., 93, 29–86.
Bellacosa A, Testa JR, Staal SP and Tsichlis PN . (1991). Science, 254, 274–277.
Cheng JQ, Lindsley CW, Cheng GZ, Yang H and Nicosia SV . Oncogene Rev., 24, 7482–7492.
Coffer PJ and Woodgett JR . (1991). Eur. J. Biochem., 201, 475–481.
Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN . (1995). Cell, 81, 727–736.
Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.
Jones PF, Jakubowicz T, Pitossi FJ, Maurer F and Hemmings BA . (1991). Proc. Natl. Acad. Sci. USA, 88, 4171–4175.
Staal SP . (1987). Proc. Natl. Acad. Sci USA, 84, 5034–5037.
Staal SP, Hartley JW and Rowe WP . (1977). Proc. Natl. Acad. Sci. USA, 74, 3065–3067.
Acknowledgements
This work was supported by NIH Grants CA77429, CA83638 (SPORE in Ovarian Cancer), CA57436 and CA06927, and by an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Testa, J., Tsichlis, P. AKT signaling in normal and malignant cells. Oncogene 24, 7391–7393 (2005). https://doi.org/10.1038/sj.onc.1209100
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209100
Keywords
This article is cited by
-
Ketotifen directly modifies the fibrotic response of human skin fibroblasts
Scientific Reports (2024)
-
Investigation of the inhibitory behavior of XFE and mitoxantrone molecules in interaction with AKT1 protein: a molecular dynamics simulation study
Journal of Molecular Modeling (2023)
-
Effects of Agarum clathratum extract on cell death and calcium ion levels of ovarian cancer cell
Molecular & Cellular Toxicology (2023)
-
Identification of co-expression hub genes for ferroptosis in kidney renal clear cell carcinoma based on weighted gene co-expression network analysis and The Cancer Genome Atlas clinical data
Scientific Reports (2022)
-
A New Cell Signal Regulation Theory: Blocking the Signal from being Reactivated Before a New Activation
Cell Biochemistry and Biophysics (2022)